COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosing and treating certain types of cancers, announced that CEO Ulrich Krasilnikoff and CMO prof. Andreas Kjær will be in San Francisco during the 44th J.P. Morgan Healthcare Conference being held January 12-15, 2026. During the week,… Continue reading Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
Tag: Morgan
Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosing and treating certain types of cancers, announced that CEO Ulrich Krasilnikoff and CMO prof. Andreas Kjær will be in San Francisco during the 44th J.P. Morgan Healthcare Conference being held January 12-15, 2026. During the week,… Continue reading Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
Morgan Stanley Raises Its Price Target On BorgWarner Inc. (BWA)
BorgWarner Inc. (NYSE:BWA) is among the 9 Best Auto Stocks to Buy Now. Morgan Stanley Raises Its Price Target On BorgWarner Inc. (BWA) According to TheFly, on December 8, 2025, Morgan Stanley reduced BorgWarner Inc. (NYSE:BWA) to Equal Weight from Overweight and boosted its price objective to $49 from $42 due to an analyst coverage… Continue reading Morgan Stanley Raises Its Price Target On BorgWarner Inc. (BWA)
Dana Incorporated Completes Sale of Off-Highway Business
MAUMEE, Ohio, Jan. 2, 2026 /PRNewswire/ — Dana Incorporated (NYSE: DAN) today announced the completion of its previously disclosed sale of the Off-Highway business to Allison Transmission Holdings, Inc. (NYSE: ALSN; “Allison”) for $2.7 billion. Dana Incorporated logo. (PRNewsFoto/Dana Incorporated) The transaction, valued at 7.5 times the Off-Highway business’s expected 2025 adjusted EBITDA, represents a significant… Continue reading Dana Incorporated Completes Sale of Off-Highway Business
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
MARLBOROUGH, Mass., Jan. 2, 2026 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026, in San Francisco. Mike Mahoney, chairman and chief executive officer, Jon Monson, executive vice president and chief financial officer, and Ken Stein, M.D., senior vice president and global chief medical… Continue reading Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
BRIDGEWATER, N.J., Jan. 2, 2026 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco, on Monday, January 12, 2026, at 3:00… Continue reading Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 2, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 7:30 am Pacific Time. The public may access Mr. Simon’s presentation live via audio webcast at: https://jpmorgan.metameetings.net/events/healthcare26/sessions/317152-haemonetics-corp/webcast?gpu_only=true&kiosk=true The live… Continue reading Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
Focusing on global out-licensing of Phase 2 assets PF1801 and PF1804. Company to engage with global big pharma in San Francisco to accelerate U.S. clinical entry. SEOUL, South Korea, Jan. 1, 2026 /PRNewswire/ — ImmunoForge Co., Ltd. (Co-CEOs Sung-Min Ahn and Kiho Chang), a clinical-stage biopharmaceutical company specializing in rare diseases, today announced that its… Continue reading ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
DigitalBridge and Crestview Partners Complete Take-Private Acquisition of WideOpenWest (WOW!)
$1.5 billion transaction to expand fiber deployments, launch network modernization initiatives, and accelerate growth BOCA RATON, Fla., Dec. 31, 2025 /PRNewswire/ — DigitalBridge Group, Inc. (“DigitalBridge” or the “Company”) (NYSE: DBRG), a leading global alternative asset manager dedicated to investing in digital infrastructure, and Crestview Partners (“Crestview”), a leading private equity firm, today announced that affiliated investment… Continue reading DigitalBridge and Crestview Partners Complete Take-Private Acquisition of WideOpenWest (WOW!)
Clean Technica: Tesla Press Release Predicts Sales Decline004307
Support CleanTechnica’s work through a Substack subscription or on Stripe. Tesla did something yesterday that no one at CleanTechnica’s palatial global headquarters ever remembers it doing in the past. On the press releases page of its website, it published quarterly and year-end sales predictions by several financial analysts, including Daiwa, DB, Wedbush, OpCo, Canaccord, Baird,… Continue reading Clean Technica: Tesla Press Release Predicts Sales Decline004307